Introduction. Modern treatment of Hodgkin?s lymphoma has led to a cure in 60-90% patients. The problem are patients whom disease relapse occurs, or the is refractory initial therapy. standard application high-dose chemotherapy with autologous stem cell transplantation. However, about half experience failure after Despite new therapeutic modalities, relapses, so allogeneic transplantation method...

BACKGROUND AND OBJECTIVES Living donor kidney transplantation, the treatment of choice for ESRD, is underused by women and blacks. To better understand sex differences in the context of potential barriers to living donor kidney transplantation, the Dialysis Patient Transplant Questionnaire was administered in two urban, predominantly black hemodialysis units. DESIGN, SETTING, PARTICIPANTS, & ...

Patients with severe aplastic anemia who do not have a human leukocyte antigen (HLA)-identical sibling generally receive immunosuppressive therapy as a first-line therapy, with allogeneic transplantation being reserved for those who do not have an adequate sustained response. Barriers to the use of unrelated-donor transplantation for aplastic anemia include identifying a suitable alternative do...

Paediatric kidney transplantation into adult recipients is a well-recognised technique. However, there are different opinions regarding two methods of transplantation. These two opinions are single kidney transplantation (SKT) and en bloc kidney transplantation (EBKT) from donors up to 20 kg. We are reporting the first successful en bloc kidney transplantation from a small, paediatric donor int...

Eighty-eight children 0.5 to 17 years of age (median, 9 years of age) received an unrelated donor marrow transplant for treatment of chronic myeloid leukemia (CML; n = 16), acute lymphoblastic leukemia (ALL) in first or second remission (n = 15) or more advanced stage (n = 28), acute myeloid leukemia (AML; n = 13), or other hematologic diseases (n = 16) between June 1985 and April 1993. All pat...

BACKGROUND There are growing numbers of patients with end-stage renal disease globally at an unexpected rate. Today, the most serious challenge in transplantation is organ shortage; hence, using deceased donor is increasingly encouraged. OBJECTIVES The aim of the study was to investigate the differences in survival rates between kidney transplant recipients with deceased donor and living dono...

With cross-over living donor kidney transplantation, immunologic incompatibilities within the original donor/recipient pair can be overcome. As minimal invasive techniques for organ recovery are increasingly applied, this should also be performed in a cross-over kidney transplantation. We present the first report of a successful simultaneous laparoscopic kidney recovery for cross-over kidney tr...

The Editors of Transplantation are pleased to present to their readers this supplement which records the consensus of an International Forum on the care of the Live Kidney Donor held in Amsterdam, The Netherlands from April 1-4, 2004. The objective of the meeting was to develop an international consensus on the standard of care and a position statement of The Transplantation Society defining an...